Deep Dive

Vertex Pharmaceuticals is a company that invests in scientific innovation to create transformative medicines for people with serious diseases. Their primary focus is on discovering, developing, and producing innovative medicines so that individuals with serious diseases can lead better lives.Key aspects of Vertex Pharmaceuticals include:​Mission and Patient Focus: The company is built on an inclusive culture that unites individuals from various fields, all striving towards the singular goal of improving the lives of people with serious diseases. They are "relentless in [their] quest to improve the lives of people living with serious diseases". This commitment guides their efforts, particularly in areas like cystic fibrosis, where they are "uncompromising" in their dedication to patients.​Scientific Approach: Vertex's scientists approach challenges by seeing "the impossible as a good place to start" for scientific discovery. They are deeply committed to scientific innovation.​Impact and Value: Through their transformative medicines for patients, Vertex aims to drive value for their company, shareholders, and society.​Patient Support and Community Engagement: Beyond developing medicines, Vertex provides comprehensive programs that offer personalized support throughout a patient's treatment journey with a Vertex medicine. They also actively engage with patient communities, such as working with the kidney community to ensure their voices are represented and engaging with the sickle cell disease community.​Clinical Research: They conduct clinical trials, noting that volunteers who participate in these trials help make new medicines a reality.​Corporate Responsibility: Their innovation process is guided by values such as fearlessness, diversity, collaboration, and a commitment to patients, which also fuel their corporate responsibility efforts. They regularly report on how they operate their business responsibly and their positive impact on patients, employees, communities, and the environment.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Zepz, the parent company of WorldRemit and Sendwave, secured a significant €152 million financing facility to improve its global money transfer services. This new funding, led by HSBC, replaces a previous arrangement and will enable Zepz to invest in faster, more affordable, and more reliable cross-border payments. The company, founded in 2021, facilitates millions of monthly transactions across numerous countries. Zepz's mission is to reduce financial barriers for migrants, and this investment reflects market confidence in its growth and leadership in the remittance sector.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

WilsonAI is an AI-powered legal assistant designed to streamline in-house legal operations by automating routine tasks such as answering common questions and reviewing contracts. The company aims to reduce response times, optimize legal spending, and accelerate deal flow, offering a data-driven approach to track and improve legal processes. WilsonAI has secured €1.6 million in pre-seed funding to further develop its Legal Large Action Model (LLAM) and expand integrations with existing legal tech. Co-founders Gus Neate and Alex Wang emphasize that WilsonAI enables legal teams to focus on strategic initiatives, with early users reporting significant time savings. The AI paralegal is currently deployed in several high-growth tech companies and can automate over 50% of routine legal queries while accelerating contract reviews by up to 70%. The funding round included investments from Nomad Ventures, Autopilot Ventures, and other strategic investors.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Legora, a LegalTech company that recently secured €70.6 million in Series B funding, bringing their total raised to €105 million and valuing the company at €596 million. Legora's core offering is a collaborative AI platform designed specifically for legal professionals, enabling faster review, smarter drafting, and deeper research. The funding round was led by ICONIQ and General Catalyst, and Legora plans to use the investment to accelerate product development and continue its collaborative approach with clients. The platform is already being used by over 250 law firms and in-house legal teams globally, aiming to revolutionize legal workflows and enhance the efficiency of lawyers.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Ontik, a British startup focused on automating B2B trade credit for wholesalers, which recently secured €3.2 million in seed funding led by Firstminute Capital to modernize financial operations in sectors still relying on manual processes. Ontik's platform automates the order-to-cash cycle, from creating and tracking payment requests through various channels like SMS and email to integrating with existing ERP systems for seamless reconciliation. The company's technology aims to significantly reduce collection efforts and payment days, improve cash flow, and decrease card fees for businesses. Described as building the "Stripe for the real economy," Ontik provides a mobile-friendly customer payment portal and a dashboard for managing collections, ultimately helping wholesalers operate with greater efficiency and improve their margins.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

AMBOSS is a medical technology company founded by physicians in 2012 that has developed a comprehensive digital platform for medical knowledge and clinical decision support. This platform serves both medical students for exam preparation and clinicians for point-of-care guidance, utilizing an extensive library and question bank. Recent news indicates significant growth and investment, including a €240 million financing round aimed at expanding its reach to new markets and healthcare professionals like nurses. AMBOSS emphasizes providing evidence-based, up-to-date medical information through technology, with a growing user base exceeding one million healthcare professionals across numerous countries. The company also focuses on innovation and has made strategic acquisitions to enhance its offerings, solidifying its role as a key resource in medical education and practice.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

App Alchemy is an AI tool designed to help users create mobile app designs:​It allows you to design your own apps with AI.​It can quickly generate designs for your ideas.​The process involves describing the app design you want to create.​App Alchemy then generates your UI design instantly with a real-time preview.​You can use a chat editor to refine the design and add visual elements.​It is presented as a way to generate stunning, professional app designs instantly.​Compared to hiring designers or doing it manually, App Alchemy is described as Fast, affordable, and high-quality.​Users have found it helpful for saving money and getting an MVP (Minimum Viable Product) ready for beta testers and investors.​Users also report that it helps create beautiful interfaces faster and provides full control over design assets.​It is described as making the app interface design process intuitive and efficient, transforming the workflow by allowing instant visualization of designs.In essence, App Alchemy is an AI-powered alternative for generating app designs quickly and cost-effectively.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Cursor is an AI Code Editor. It is built with the goal of making developers extraordinarily productive and is described as the best way to code with AI.Key aspects and features of Cursor include:​AI-Powered Assistance: It functions as an AI pair programmer. It uses "Frontier Intelligence" powered by a mix of purpose-built and frontier models.​Predictive Editing: Cursor helps users "breeze through changes by predicting your next edit". This tab completion feature is highlighted by users as being highly effective, sometimes anticipating exactly what is needed and allowing coding "at the speed of thought". It can predict what code is wanted based on what the user is doing and allows acceptance by hitting tab. It can also propose multi-line edits.​Codebase Understanding: It knows your codebase and can analyze it. This allows users to get answers from their codebase or refer to files and documentation.​Natural Language Interaction: Users can write code using instructions and update entire classes or functions with a simple prompt. It can also write things like a README for a project by analyzing the code.​Suggesting Edits: Cursor suggests edits to existing code, even noticing inconsistencies in markup.​Familiar Experience: It is designed to feel familiar, allowing users to import all their extensions, themes, and keybindings in one click. It is fast and handles brackets properly, with sensible keyboard shortcuts.​Privacy: Cursor offers Privacy Options, including a Privacy Mode where code is never stored remotely. It is also SOC 2 certified. Users can also bring their own model.​User Perception: Many engineers describe Cursor as a significant improvement, a "necessity", the "best AI developer tool", and a "game-changer". Several users mentioned switching from VSCode to Cursor.In essence, Cursor is described as an AI-enabled editor that deeply integrates artificial intelligence into the coding workflow. This concept is compared to how "WillBot" applies AI to marketing data and tasks, suggesting that Cursor revolutionized coding workflows by applying AI in a similar transformative way. Cursor is considered a software development tool.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Marblism, a platform offering AI Employees designed to automate various business tasks, allowing entrepreneurs to focus on core activities instead of juggling multiple roles. These AI agents specialize in areas like customer support, SEO blog writing, executive assistance, social media management, sales outreach, and legal assistance, aiming to save users time and money. The service highlights ease of use with no prompting skills required, offers a money-back guarantee, provides customer support and onboarding, integrates with popular software, allows managing multiple businesses, and emphasizes that the AI Employees learn and improve based on user interaction.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Clay is presented as a platform designed to streamline go-to-market strategies for businesses by integrating numerous data sources and leveraging AI for automation. It focuses on improving CRM data, sourcing leads, scoring accounts, and tracking intent signals to enhance sales and marketing efforts. The company's LinkedIn page further emphasizes its role as a "creative tool for growth," highlighting its features for data enrichment and personalized outreach automation, along with community engagement and recent product updates. Clay aims to empower growth teams with efficient workflows and data-driven insights.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Augustine Therapeutics has successfully secured €78 million in Series A funding to further its development of novel therapies. The company is focused on inhibiting the HDAC6 enzyme to treat neuromuscular, neurodegenerative, and cardio-metabolic diseases. Their approach utilizes a unique, non-hydroxamate and non-hydrazide producing chemotype, which aims to be more selective and safer than previous HDAC6 inhibitors. The lead program, AGT-100216, is intended for the treatment of Charcot-Marie-Tooth Disease and will advance into clinical trials with this funding. The financing was led by Novo Holdings and Jeito Capital, with participation from existing and new investors.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Atlas Research Beta 1.0 is a newly released platform designed to create a unified, AI-powered research environment. This tool aims to combine code notebooks, writing tools, and reference management for researchers and data professionals. Inspired by the concept of literate programming, it seeks to connect documentation directly with executable code. Key benefits include a consolidated workspace, AI assistance for coding and writing, and the linking of research materials. The platform targets academics, data scientists, quantitative finance professionals, students, and anyone involved in computationally intensive research. Essentially, Atlas Research strives to streamline the research process by integrating essential tools and offering AI support.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

n8n, a Berlin-based company, has secured €55 million in Series B funding for its AI-powered workflow automation platform designed for technical teams. This funding will fuel product development, team expansion, and the opening of new offices in New York and London. n8n's platform emphasizes transparency, customization, and cost efficiency, offering a flexible environment that combines code-based precision with no-code speed and boasts a large, active user community. The company aims to address the limitations of existing automation tools by enabling the creation of complex, high-volume workflows with extensive integrations and control, appealing to both enterprises and individual users.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Ergo is presented as an intelligent CRM automation tool designed to eliminate manual data entry and streamline sales processes. It aims to provide users with a well-maintained CRM without the burden of constant manual updates. The platform boasts features like automated data entry, seamless integration with existing tools, and the automation of sales tasks. Testimonials highlight significant time savings, improved sales cycle length, and increased revenue recovery. By automatically syncing customer interactions and ensuring follow-ups, Ergo intends to provide real-time pipeline visibility and facilitate smoother team collaboration.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich

Cursor is presented as an AI-powered code editor designed to enhance developer productivity through features like intelligent code completion and natural language editing. The company promotes its software on its website, highlighting its speed, familiarity, privacy options, and trust from various engineering teams. LinkedIn profiles for Cursor detail it as a software development company with a specific employee size. Additionally, a LinkedIn post from Hamza Alsamraee discusses creating "WillBot," an AI-powered marketing assistant inspired by Cursor's functionality, aiming to revolutionize marketing workflows similarly to how Cursor impacts coding. These sources collectively introduce and promote Cursor as an innovative tool and showcase its potential influence in other fields.Podcast creator page: http://santarovich.tilda.ws/Support our podcast with your donations: https://paypal.me/OlgaSantarovich